Epidemiology of Primary Headache and Its Associated Psychosocial Factors Amongst Undergraduate Medical Students: A Cross-Sectional Study From the Vidarbha Region Scientific literature GHDx Entry last modified on: Mar 22, 2024
Employees of the banking sector in Guizhou Province in China: prevalence of migraine, symptoms, disability and occupational risk factors Scientific literature GHDx Entry last modified on: Mar 22, 2024
Brazilian Dialysis Survey 2021 Censo Brasileiro de Diálise 2021 Scientific literature GHDx Entry last modified on: Mar 22, 2024
Brazilian Dialysis Survey 2022 Censo Brasileiro de Diálise 2022 Scientific literature GHDx Entry last modified on: Mar 22, 2024
A second dramatic rise in seroprevalence rates of SARS-CoV-2 antibodies among adult healthy blood donors in Jordan; have we achieved herd immunity? Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Presence of antibodies to SARS-CoV-2 in Sweden, 26 April - 9 May 2021 Förekomsten av antikroppar mot SARS-CoV-2 i Sverige, 26 april – 9 maj 2021 Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Andhra Pradesh: '59% found to have Covid antibodies in sero-survey' Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Longitudinal SARS-CoV-2 seroprevalence in Portugal and antibody maintenance 12 months after the start of the COVID-19 pandemic. Preprint Scientific literature GHDx Entry last modified on: Sep 13, 2022
Brazil - Sergipe Evolution of the Prevalence of SARS-CoV-2 Infection 2021, Third Phase Evolução da Prevalência de Infecção por SARS-CoV-2 em Sergipe. Terceira Fase: 18 de fevereiro a 30 de março de 2021. Survey: Epi surveillance GHDx Entry last modified on: Jul 13, 2022
Jharkhand: 45% of population in 10 districts positive before 2nd wave: Sero survey Survey: Epi surveillance GHDx Entry last modified on: Aug 2, 2022
SARS-CoV-2 seroprevalence in Chattogram, Bangladesh before a National Lockdown, March-April 2021. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Anti-spike protein receptor-binding domain IgG levels after COVID-19 infection or vaccination against SARS-CoV-2 in a seroprevalence study. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care Scientific literature GHDx Entry last modified on: Mar 22, 2024
Seropositivity highest in Madhya Pradesh, lowest in Kerala, finds ICMR's national sero-survey Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022
Questionnaire-Based Survey during COVID-19 Vaccination on the Prevalence of Elderly's Migraine, Chronic Daily Headache, and Medication-Overuse Headache in One Japanese City-Itoigawa Hisui Study Scientific literature GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 antibody prevalence in Sierra Leone, March 2021: a cross-sectional, nationally representative, age-stratified serosurvey. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Prevalence of migraine and tension-type headache among undergraduate medical students of Kathmandu Valley: A cross-sectional study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Socioeconomic position and SARS-CoV-2 infections: seroepidemiological findings from a German nationwide dynamic cohort. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Migraine attacks among Lebanese university medical students: A cross sectional study on prevalence and correlations Scientific literature GHDx Entry last modified on: Mar 22, 2024
COVID-19 antibody seroprevalence in Duhok, Kurdistan Region, Iraq: A population-based study. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Primary Headaches and Physical Performance: A Professional Youth Female Soccer Team Study Scientific literature GHDx Entry last modified on: Mar 22, 2024
School-based online survey on chronic headache, migraine, and medication-overuse headache prevalence among children and adolescents in Japanese one city - Itoigawa Benizuwaigani study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Serological prevalence of SARS-CoV-2 antibody among children and young age (between age 2-17 years) group in India: An interim result from a large multi-centric population-based seroepidemiological study. Preprint Scientific literature GHDx Entry last modified on: Apr 8, 2022
Brazil - São Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 5 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 5 Survey GHDx Entry last modified on: Jun 26, 2023
Seroprevalence of SARS-CoV-2 infection in the Colombo Municipality region, Sri Lanka. Preprint Scientific literature GHDx Entry last modified on: Mar 14, 2022
Neuroepidemiology study of headache in the region of Jammu of north Indian population: A cross-sectional study Scientific literature GHDx Entry last modified on: Mar 22, 2024
Prevalence of SARS-CoV-2 antibodies in Denmark 2020: results from nationwide, population-based sero-epidemiological surveys. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
South Africa COVID-19 Special Public Health Surveillance Bulletin, Volume 18 Supplementary Issue 9, 12 March 2021 COVID-19 Special Public Health Surveillance Bulletin Volume 18 (Issue 9: 12 Mar 2021) Epi surveillance: Cross-sectional - Individual GHDx Entry last modified on: Sep 9, 2022
Malawi Standardized Monitoring and Assessment of Relief and Transitions Nutrition Survey Round 7 2020 Malawi Round Seven SMART Nutrition Survey 2020 Survey: Cross-sectional - Household GHDx Entry last modified on: Jul 10, 2023
Puerto Rico Community Assessment for Response to Public Health Emergencies (CASPER) 2020 Evaluación Comunitaria para la Respuesta a Emergencias de Salud Pública (CASPER) Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, Cities of Xai-Xai and Chókwè (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Xai-Xai e Chókwè (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
33.98% of Tripura has COVID-19 antibody in them, shows sero survey Survey: Epi surveillance GHDx Entry last modified on: May 12, 2022
Seroprevalence of antibodies against SARS-CoV-2 virus in the adult Norwegian population, winter 2020/2021: pre-vaccination period. Preprint Scientific literature GHDx Entry last modified on: May 12, 2022
Brazil - Maranhão Prevalence of SARS-CoV-2 Virus Infection Survey 2020 Phase II Prevalência de infecção pelo vírus SARS-CoV-2 no Maranhão, segunda fase Survey: Individual - Interview GHDx Entry last modified on: Oct 21, 2022
4.7% of the Austrian population had antibodies against SARS-CoV -2 in mid / late October Epi surveillance GHDx Entry last modified on: May 12, 2022
Brazil - Sao Paulo Household Survey to Estimate the Seroprevalence of SARS-CoV-2 Infection, Phase 4 (SoroEpi MSP) Avaliação da prevalência da infecção pelo vírus SARS-CoV-2 em habitantes do município de São Paulo: Resultados Parciais da Fase 4 Survey GHDx Entry last modified on: Jun 26, 2023
Andhra Pradesh Sero Survey Show Nearly 20% of State’s Population Exposed to Covid-19 Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: May 12, 2022
20% of Andhra Exposed to Covid, Sero-survey Finds, Exposure Highest Where Case Tally Lowest Survey: Cross-sectional - Epi surveillance - Urban only GHDx Entry last modified on: Aug 1, 2022
Seroprevalence of SARS-CoV-2 Infection Among Occupational Groups from Bucaramanga Metropolitan Area, Colombia. Preprint Scientific literature GHDx Entry last modified on: Oct 5, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Lichinga (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Lichinga (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Beira (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Beira (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Tete (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Tete (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Aug 2, 2022
Over 56% of Delhi has Covid-19 Antibodies: Health Minister Satyendar Jain on 5th Serosurvey Survey: Urban only GHDx Entry last modified on: Apr 8, 2022
Prevalence and Time Trend of SARS-CoV-2 Infection in Puducherry, India, August-October 2020 Scientific literature GHDx Entry last modified on: Jun 17, 2021
Mexico National Health and Nutrition Survey (ENSANUT) about COVID-19 2020 Encuesta Nacional de Salud y Nutrición 2020 sobre Covid-19, ENSANUT Continua COVID-19 Epi surveillance: Household - Interview - Urban-rural representative GHDx Entry last modified on: Jul 21, 2023
[Preliminary results of the National Health and Nutrition Survey COVID-19] Communiqué 255: Resultados preliminares de la Encuesta Nacional de Salud y Nutrición COVID-19 Survey: Cross-sectional - Epi surveillance - Household - Individual - Nationally representative GHDx Entry last modified on: May 12, 2022
Serum-epidemiological Survey of SARS-CoV-2, City of Maputo (InCOVID 2020) - Preliminary Results Inquérito Sero-epidemiológico de SARS-CoV-2 nas Cidades de Maputo (InCOVID 2020) - Resultados Preliminares - Epi surveillance GHDx Entry last modified on: Apr 1, 2024
Assam's Sero-survey found 23.7 per cent Seroprevalence in the State Survey: Epi surveillance GHDx Entry last modified on: Aug 1, 2022